'The Effect of Adding LFCN Block to PENG
The Effect of Adding Lateral Femoral Cutaneous Nerve Block to PENG Block on Postoperative Opioid Consumption in Hip Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
The incidence of femoral neck fracture in Europe is 330/10000 per year. It is increasing every year due to the aging of the population. In patients 55 years and older, hip fracture-related mortality is estimated to be between 4% and 16% at one month and between 11% and 43% at one year after surgery. The reduced risk of postoperative complications associated with the use of regional anesthesia, shorter mobilization times, and reduced morphine consumption in hip fractures have been reported, and have been incorporated into postoperative pain control as part of multimodal strategies. PENG has been described for postoperative pain control for surgery on the hip joint or for the treatment of post-traumatic pain associated with proximal femur/femoral head fractures. Lateral femoral cutaneous nerve block is used in combination with other peripheral block methods to provide analgesia in the lateral thigh. The investigators aimed to evaluate the effect of adding lateral femoral cutaneous nerve block to PENG block on pain scores and opioid consumption in femoral fracture procedures under spinal anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 4, 2024
CompletedFirst Posted
Study publicly available on registry
January 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedJanuary 26, 2024
January 1, 2024
1.1 years
January 4, 2024
January 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative opioid consumption
total morphine requirement
up to 24 hour after surgery
Secondary Outcomes (4)
pain scores
up to 24 hour after surgery
first analgesic time
up to 24 hour after surgery
postoperative complications
up to 24 hour after surgery
mobilization time
up to 24 hour after surgery
Study Arms (3)
Group Control
NO INTERVENTIONGroup PENG
ACTIVE COMPARATORGroup PENG+LFCN
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- years old,
- ASA I-II-III risk group
- patients undergoing hip fracture surgery under spinal anesthesia
- Patients whose informed consent was read and consent was obtained from them and their representatives.
You may not qualify if:
- Those who do not want to participate in the study,
- ASA IV-V patients
- Those with coagulation disorders
- Allergic to local anesthetics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zonguldak Bülent Ecevit University
Zonguldak, Kozlu, 67600, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 4, 2024
First Posted
January 26, 2024
Study Start
January 1, 2023
Primary Completion
January 31, 2024
Study Completion
April 1, 2024
Last Updated
January 26, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share